David B. McWilliams

Statistics

Publications

Citations

H-Index

Active since

2016

Affiliations

The University of Texas Medical Branch at Galveston(Current)

David B. McWilliams is an author at The University of Texas Medical Branch at Galveston specializing in vaccination, replication-defective vectors, and adenoviral vaccine vectors.

Publications per year

2016–2021

Publications

A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates

Jian Sha, Michelle L. Kirtley, Curtis Klages et al. · Clinical and Vaccine Immunology · 2016 · 29 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Final five-year median follow-up safety data from a prospective, randomized, placebo-controlled, single-blinded, multicenter, phase IIb study evaluating the use of HER2/neu peptide GP2 + GM-CSF vs. GM-CSF alone after adjuvant trastuzumab in HER2-positive women with operable breast cancer.

Snehal G. Patel, David B. McWilliams, Christine T. Fischette et al. · Journal of Clinical Oncology · 2021 · 10 citations

Medicine, Immunology, Oncology +14

1–2 of 2